Nucleus Network operates two early phase clinical trial units at the Centre for Clinical Studies. It is in these units that new drugs and compounds are administered to clinical research volunteers in a strictly controlled environment, attended to 24 hours a day by Nucleus Network’s specially trained medical support staff. Participants in trials are watched closely for any reactions and have blood samples, blood pressure and other vital signs taken and carefully recorded at regular intervals. The information collected monitors and protects the participant’s health and also provides crucial information about the therapy under trial. These participant profiles inform the pharmaceutical company’s understanding of the drug and acre a crucial part of the development of the therapy.
The clinical trials performed at Nucleus Network involve either healthy volunteers or, sometimes, patients with specific medical conditions. We rely heavily on community involvement in this process, and are grateful for the time and effort offered by our volunteers, without whom new medicines would not reach the people who need them most
With our network of peer reviewed clinicians and management staff, Nucleus Network has the breadth and depth of capabilities and experience to assist Sponsors to anticipate obstacles, avoiding them whenever possible during the clinical development process.
We conduct trials customised to Sponsors’ needs, servicing small or large biotech, medical device or pharma companies. We always ensure effective facilitation of communication between the Sponsor and the investigator to ensure that any study related issues are addressed in a timely manner.
All our clinical research is conducted to high quality, audit-ready research, that is internationally recognised to the accepted standards of Good Clinical Practise as defined by the Therapeutics Goods Administration (TGA), International Conference on Harmonisation(ICH) and the Food and Drug Administration (FDA).
Experience
We are accomplished in conducting clinical research programs using the latest techniques and a coordinated, collaborative approach to clinical research. All our trials are conducted in a timely and efficient manner.
View list of clincial trials conducted at Nucleus Network.
Nucleus Network has conducted numerous studies for multi-national pharmaceutical companies and international biotechnology companies, testing novel applications utilising chemical entities, biologics or peptide compounds for clinical trials in therapeutic areas such as heart disease, diabetes, dermatology, hepatitis, metabolic disease, cancer and neurosciences.
We deliver solutions to Industry for managing the bio-pharmaceutical product lifecycle to assist Sponsors with the goal to reduce the time, risk and cost associated with the development and commercialisation of new medicines and devices.
Study facility capabilities
- Telemetry units to all dosing beds
- Call bell services to all beds
- Oxygen and suction available to all beds
- Recreational and computer rooms
- Dedicated study monitor area
- Technical Laboratory with centrifuges and temperature monitored -70ºC, -20ºC and 2-8ºC storage facilities for samples
Volunteers and Specialised Patient Groups
- Caucasian, Japanese and Chinese Cohorts
Types of Studies
- Proof of concept
- First time in man
- Pharmacokinetic/ Pharmacodynamic
- Bio-equivalence/ Bio-availability
- Drug interaction
- Ethnopharmacology
Pharmacy Services
- Full time Clinical Trial Pharmacists
- Capabilities include aseptic reconstitution, cytotoxic admixing, blinded packaging, comparator supply, labelling, import permits and temperature monitored storage
- Radio-pharmacy
Full Range of Clinical Testing Services:
- Cardiology (Echo, ECH, Holter monitoring)
- Vascular (Duplex Scans, ABI)
- Respiratory function testing (Full range)
- Neuroscience testing (Ultrasound, EEG, EMG, NCS, evoked potentials)
- Sleep laboratory testing
- X-Ray, CT, MRI, Pet Scanning
